Levi & Korsinsky Investigates Novo Nordisk A/S (NVO) Over Potential Securities Fraud Allegations
NEW YORK, NY / ACCESS Newswire / July 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Novo Nordisk A/S ("Novo Nordisk A/S") (NYSE:NVO) concerning possible violations of federal securities laws. Novo Nordisk announced on June 23, 2025, that it would end its partnership with Hims & Hers Health, […]